HealthEquity Inc (HQY)
Return on assets (ROA)
| Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 96,703 | 96,702 | 105,672 | 80,431 | 55,712 | 29,139 | 12,825 | -8,410 | -26,143 | -58,752 | -62,149 | -55,313 | -44,289 | -6,104 | 723 | 4,393 | 8,834 | 3,277 | -19,846 | -332 |
| Total assets | US$ in thousands | 3,448,550 | 3,488,350 | 3,514,470 | 3,246,480 | 3,163,790 | 3,093,500 | 3,066,460 | 3,035,010 | 3,088,900 | 3,064,760 | 3,074,020 | 3,065,070 | 3,107,100 | 3,099,610 | 3,148,630 | 3,161,870 | 2,710,410 | 2,657,260 | 2,664,380 | 2,562,480 |
| ROA | 2.80% | 2.77% | 3.01% | 2.48% | 1.76% | 0.94% | 0.42% | -0.28% | -0.85% | -1.92% | -2.02% | -1.80% | -1.43% | -0.20% | 0.02% | 0.14% | 0.33% | 0.12% | -0.74% | -0.01% |
January 31, 2025 calculation
ROA = Net income (ttm) ÷ Total assets
= $96,703K ÷ $3,448,550K
= 2.80%
HealthEquity Inc's return on assets (ROA) has been volatile over the past few years, ranging from negative to positive values. The ROA was negative in the initial quarters of the data provided, reaching its lowest point of -2.02% in July 2022.
However, starting from October 2023, there was a significant improvement in the ROA, with positive values reported for each subsequent quarter. The ROA steadily increased from 0.94% in October 2023 to 2.80% in January 2025, showing a positive trend in the company's ability to generate profits relative to its total assets.
Overall, HealthEquity Inc's ROA indicates that the company has managed to improve its profitability and efficiency in utilizing its assets effectively over the period covered in the data. It is important for investors and analysts to closely monitor future ROA trends to assess the company's continued financial performance.
Peer comparison
Jan 31, 2025